Retatrutide: A Research Overview

Retatrutide is one of the most talked-about peptides in current metabolic research, and for good reason: it belongs to a new generation of molecules designed to act on more than one receptor at once. Where earlier research peptides targeted a single pathway, retatrutide is described as a “triple agonist” — it engages three distinct receptors simultaneously.

The three targets: GLP-1, GIP and glucagon

Retatrutide is studied for its activity at the GLP-1 receptor, the GIP receptor and the glucagon receptor. Each plays a different role in how the body manages energy and metabolism. GLP-1 and GIP are “incretin” receptors, closely tied to glucose regulation, while the glucagon receptor is involved in energy expenditure. The interesting question for researchers is what happens when all three are engaged together — a combination that single- and dual-agonist peptides cannot replicate.

Why a triple agonist is significant

Much of the attention around retatrutide in the scientific literature comes from this multi-receptor approach. By acting on three pathways at once, it gives researchers a way to study how these systems interact rather than examining them in isolation. This is why retatrutide is frequently referenced in comparative metabolic research alongside dual-agonist peptides such as tirzepatide.

Formats available

Auriva supplies retatrutide in several research formats. Lyophilised vials suit laboratories that prefer to reconstitute and measure the compound themselves, giving full control over preparation. Pre-filled pens offer a more convenient, ready-to-handle format. Each is supplied with the same focus on purity and secure presentation.

Handling and storage

Like most lyophilised peptides, retatrutide is kept cool and protected from light, and handled using standard good laboratory practice. Every Auriva vial also includes complimentary bacteriostatic water for reconstitution, with an optional pre-mixing service for labs that prefer it ready to use.

Important

Retatrutide is supplied strictly for laboratory, analytical and research purposes only. It is not for human consumption and is not a medicine. Customers are responsible for lawful purchase and use within their jurisdiction.

Explore Auriva’s research-grade retatrutide — pens and vials — with free BAC water and next day UK delivery.